Trials / Completed
CompletedNCT00966225
LIP-01 in Hypercholesterolemia
An Open-label Dose-finding Study of LIP-01 in Otherwise Healthy Individuals With Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Afexa Life Sciences Inc · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine a safe and tolerable dose of LIP-01
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | LIP-01 | comparison of different dosages of natural health product |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2009-08-26
- Last updated
- 2012-01-31
Locations
2 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00966225. Inclusion in this directory is not an endorsement.